INS and Hypoglycemia: One exception was a randomised trial in individuals with IAH wherein an insulin analogue-based regimen produced a 29% reduction in the number of episodes of severe hypoglycaemia per person-year when compared with a regimen of soluble (regular) and NPH (intermediate-acting) insulin [21].